HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: A Safety and Immunogenicity Trial of IHV01 [Phase 1]
Phase 1 safety and immunogenicity trial of IHV01 completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-10Clinical Trial Update: A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women [Phase 4]
Phase 4 pilot trial evaluating treatment for perinatal depression in HIV-infected women has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults [Phase 1, Phase 2]
Phase 1/2 trial updating safety and immune response to an HIV-1 DNA vaccine and a booster in HIV-uninfected adults in East Africa.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children [Phase 1, Phase 2]
Clinical trial update reporting blood levels of anti-HIV drugs used in combination regimens in HIV-infected children (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors [Phase 3]
Phase 3 trial update evaluating isotretinoin for safety and effectiveness in HIV-infected women with cervical tumors/dysplasia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns [Phase 3]
A Phase 3 trial assessing the effectiveness of AZT and nevirapine in preventing HIV transmission from HIV-positive mothers to their newborns…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 [Phase 2]
A randomized Phase II study evaluating two doses of interferon alfa-2a plus AZT and ddC versus AZT and ddC alone in HIV patients with CD4 co…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating MAraViroc and/or METformin for hepatic steatosis in people living with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children [Phase 2]
Phase 2 trial evaluating the safety of different dose levels of zidovudine in HIV-infected children has been completed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients [Phase 3]
Phase 3 trial comparing zidovudine (AZT) alone versus AZT plus didanosine or AZT plus dideoxycytidine in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year [Phase 2]
Phase 2 trial comparing anti-HIV effects of saquinavir soft gelatin capsules to indinavir in patients previously treated with saquinavir har…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection [Phase 2]
Phase 2 trial investigating thalidomide for oral/esophageal aphthous ulcers and HIV viremia in HIV-infected patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy [Phase 2]
Phase 2 trial evaluating virologic responses to new nucleoside regimens after prolonged ZDV or ddI monotherapy in HIV infection.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [Phase 2]
Phase 2 clinical trial evaluating 141W94 alone or with Zidovudine and 3TC in HIV infections; completed study.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis [Phase 4]
Phase 4 trial update examining gradual initiation of sulfamethoxazole/trimethoprim as prophylaxis for Pneumocystis jirovecii pneumonia in HI…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP [Phase 3]
A Phase 3 clinical trial evaluating azidothymidine (AZT) for HIV infection in patients with AIDS who had a first episode of Pneumocystis pne…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. [Phase 2]
Phase II/III trial investigating a rifampin-containing regimen for disseminated Mycobacterium avium complex infection in HIV-infected indivi…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) [Phase 3]
A Phase 3 trial comparing sulfamethoxazole-trimethoprim to aerosolized pentamidine for secondary prophylaxis of Pneumocystis jirovecii pneum…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS [Phase 3]
Phase III trial comparing dapsone/trimethoprim and clindamycin/primaquine versus sulfamethoxazole/trimethoprim for mild-to-moderate Pneumocy…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients [Phase 3]
A Phase 3 clinical trial comparing three treatments for Pneumocystis pneumonia in AIDS patients was terminated early.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected [Phase 4]
Phase 4 trial update assessing immunogenicity, safety of a third BBIBP-CorV dose, and immune persistence in people living with HIV.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma [Phase 2]
Phase II trial evaluating zidovudine with recombinant alpha-2A interferon for AIDS-associated Kaposi's sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [Phase 3]
Phase 3 trial evaluating clarithromycin and rifabutin, alone or in combination, for prevention of MAC or disseminated MAC disease in HIV-inf…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants [Phase 3]
Phase 3 study evaluating nevirapine to prevent mother-to-child HIV transmission completed.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV [Phase 3]
Phase 3 trial investigating valganciclovir to prevent CMV organ damage in people with HIV has completed.